gastric cancer or gastro esophageal junction adenocarcinoma
Conditions
Interventions
Case series:apatinib
Sponsors
Nongken Hostipal, Heilongjiang
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18-75 years male and female; 2. Advanced gastric cancer or gastro esophageal junction adenocarcinoma patients confirmed by pathologically and previously unaccepted drug treatment; 3. ECOG 0-2;4.Estimated survival time=3 mouths; 4. Estimated survival time=3 mouths; 5. Confirmed by pathology with measurable lesions, (CT scan Long diameter of tumor=10mm, CT scan Long diameter of lymph node lesion=15mm, scan slice thickness>5mm); 6. The main organ function is normal, and meet the following standards: (1)The standard of blood routine examination should be consistent: HB=90 g/L, ANC=1.5×10^9/L, PLT=80×10^9/L (2) Biochemical tests should meet the following criteria: BIL45ml/min. 7. Fertile woman must perform a pregnancy test (serum or urine) 7 days before screened, or voluntarily adopt proper methods of contraception during the observation period and 8 week after the last given apatinib; 8. Patients voluntarily entered the study and signed informed consent form (ICF).
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating women; 2. High blood pressure and failure to be reduced to normal range by antihypertensive drugs(Systolic pressure > 140 mmHg, diastolic pressure >90mmHg); 3. Variety of factors affecting oral drugs (such as inability to swallow, chronic diarrhea, and intestinal obstruction); 4. Coagulopathy (INR>1.5×ULN APTT>1.5×ULN), with Bleeding tendency; 5. Urinary protein is more than + + and confirmed the 24 hour urinary protein quantitative>1g; 6. Received apatinib or other VEGFR inhibitors, such as bevacizumab, Solafinib, Sunitinib; 7. Metastases of the central nervous system with symptoms; 8. Other cases the researchers judged that could affect the outcome of the clinical study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PFS; | — |
Countries
China
Contacts
Public ContactGao Feng
Outcome results
None listed